CMMB vs SYF · $22.2M cap vs rev $11.19B
Chemomab Therapeutics Ltd DRC (CMMB) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
SYF (SYF) common stock.
CMMB does not have a complete income-statement cache yet.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
CMMB currently screens at market cap $22.2M. SYF currently screens at market cap $0.
Not investment advice. Open the CMMB and SYF stock pages for the full models.
Not investment advice.